Biology & biomedicineArtificial intelligence for the diagnosis of rare diseases related to collagen VI
- Details
- Category: Projects
-
30 Oct 2019
Researchers at the Institute of Robotics and Industrial Informatics -a joint center of the CSIC and the Polytechnic University of Catalonia-, and at the Sant Joan de Déu Hospital in Barcelona, have developed a system for helping in the diagnoses of rare diseases related to deficiencies in the structure of collagen VI.
A fast test for the analysis of oral tolerance to triglycerides
- Details
- Category: Technological offers
-
29 Oct 2019
The Instituto de la Grasa of the CSIC and the University of Sevilla have developed a method for analysing oral tolerance to lipids (triglycerides) from the diet, in humans, in only 4 hours. The method is easier and faster than the current ones.
Researchers develop an accommodative lens to imitate the crystalline in order to correct the presbyopia
- Details
- Category: Technological offers
-
22 Oct 2019
Scientists at the Instituto de Óptica have developed a new intraocular lens, which changes shape to focus on distant and near objects in order to imitate the crystalline lens function. It is the result of the Presbyopia project, funded by the European Research Council (ERC).
TEC-SALUT Community: RIS3CAT projects for health innovation
- Details
- Category: Laboratories
-
28 Oct 2019
RIS3 communities are groups between research institutions and companies, created at the request of the European Union to define and promote scientific projects in strategic sectors in the different European regions. In Catalonia, TEC-SALUT is one of these RIS3CAT communities. It encompasses several projects and has the participation of different CSIC centers. The goal is to create a collaborative space that responds to the challenges of the health system and health technologies.
Peptides effective for inhibiting cholesterol aggregation in the vascular wall
- Details
- Category: Projects
-
19 Jun 2019
A work demonstrates that peptides derived from a LRP1 receptor sequence are very effective inhibiting the aggregation of LDL (low density lipoprotein, also called 'bad' cholesterol) that takes place in the vascular wall during development of atherosclerosis.
Only the introduction is translated
